Startup profile · funding coverage
ArcheHealth funding, valuation and investors
AI operational intelligence platform that shows hospitals the true patient-level cost of care.
Keep track of ArcheHealth
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Seed
$6.7M · June 2025
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
$6.7M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
seed · Birmingham, AL
Investors in latest funding
Other: LRVHealth , Martin Ventures , Texas Health Resources
Overview
ArcheHealth builds an AI-infused platform that meshes clinical, financial, operational, and supply-chain data so hospitals can see actual costs of delivering care at a granular level — patients, items, and events — and act on labor, supply, and drug spend inefficiencies. CEO Ralph Keiser leads the Birmingham, AL company. In June 2025 ArcheHealth announced a $6.7M seed round funded by LRVHealth, Martin Ventures, and Texas Health Resources to scale the product and go-to-market.
Why ArcheHealth is interesting
Hospitals face margin pressure from labor and supply spend but still manage costs retrospectively. ArcheHealth’s bet is patient-event-item cost visibility — and it closed a $6.7M seed in June 2025 with health-system-aligned investors LRVHealth, Martin Ventures, and Texas Health Resources.
Product & use cases
ArcheHealth analyzes de-identified clinical, financial, and operational data from multiple hospital systems to surface process inefficiencies and true cost of care — shifting cost management from retrospective reports to actionable, proactive insight.
- Hospital CFOs and ops leaders hunting sustainable margin improvement
- Supply-chain and procure-to-pay teams benchmarking spend at item level
- Health systems wanting cost visibility tied to patient processes, not only GL summaries
Key facts
- Seed (June 2025): $6.7M from LRVHealth, Martin Ventures, and Texas Health Resources
- AI platform for patient-level hospital cost and operational intelligence
- HQ Birmingham, AL; CEO Ralph Keiser
- Targets labor, supply, and drug cost drivers without disrupting clinical workflows
Funding history (newest first)
Seed
2025-06 $6.7M- LRVHealth (participant)
- Martin Ventures (participant)
- Texas Health Resources (participant)
Source: Read source · prnewswire.com
Competitive landscape
Edge: Purpose-built cost-of-care intelligence at patient-event-item granularity, backed by provider-network investors who sell into the same buyer persona.
-
Traditional cost accounting / decision-support suites incumbent
Often retrospective and finance-led; less real-time process insight.
-
Generic hospital analytics platforms adjacent
Broad BI; may lack deep multi-source cost-of-care modeling.
Industries
Market / IPO context
Editorial / static context — not a live quote.
Related funding articles
Venture Capital Tracker pieces that cover ArcheHealth's financing or category context.
FAQs about ArcheHealth
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.